際際滷shows by User: pslice84 / http://www.slideshare.net/images/logo.gif 際際滷shows by User: pslice84 / Tue, 11 Feb 2014 19:11:37 GMT 際際滷Share feed for 際際滷shows by User: pslice84 Protalix analyst day presentation /slideshow/protalix-analyst-day-presentation/31102390 protalixanalystdaypresentationjune202013v2-140211191137-phpapp01
PLX]]>
PLX]]> Tue, 11 Feb 2014 19:11:37 GMT /slideshow/protalix-analyst-day-presentation/31102390 pslice84@slideshare.net(pslice84) Protalix analyst day presentation pslice84 PLX <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/protalixanalystdaypresentationjune202013v2-140211191137-phpapp01-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> PLX
Protalix analyst day presentation from James Hilbert
]]> 2419 8 https://cdn.slidesharecdn.com/ss_thumbnails/protalixanalystdaypresentationjune202013v2-140211191137-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Aldoxorubicin p2-sts-01 ctos poster 10-31-13 /slideshow/aldoxorubicin-p2sts01-ctos-poster-103113/29573322 aldoxorubicin-p2-sts-01ctosposter10-31-13-131230092749-phpapp02
]]>
]]> Mon, 30 Dec 2013 09:27:49 GMT /slideshow/aldoxorubicin-p2sts01-ctos-poster-103113/29573322 pslice84@slideshare.net(pslice84) Aldoxorubicin p2-sts-01 ctos poster 10-31-13 pslice84 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/aldoxorubicin-p2-sts-01ctosposter10-31-13-131230092749-phpapp02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br>
Aldoxorubicin p2-sts-01 ctos poster 10-31-13 from James Hilbert
]]> 1248 2 https://cdn.slidesharecdn.com/ss_thumbnails/aldoxorubicin-p2-sts-01ctosposter10-31-13-131230092749-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Ttrsc /slideshow/ttrsc/22941816 ttrsc-130613163505-phpapp01
]]>
]]> Thu, 13 Jun 2013 16:35:05 GMT /slideshow/ttrsc/22941816 pslice84@slideshare.net(pslice84) Ttrsc pslice84 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/ttrsc-130613163505-phpapp01-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br>
Ttrsc from James Hilbert
]]> 706 2 https://cdn.slidesharecdn.com/ss_thumbnails/ttrsc-130613163505-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Alny /slideshow/alny/22941231 alny-130613161633-phpapp01
]]>
]]> Thu, 13 Jun 2013 16:16:32 GMT /slideshow/alny/22941231 pslice84@slideshare.net(pslice84) Alny pslice84 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/alny-130613161633-phpapp01-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br>
Alny from James Hilbert
]]> 631 2 https://cdn.slidesharecdn.com/ss_thumbnails/alny-130613161633-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Asco 2012 abstract_45010_oral_final /slideshow/asco-2012-abstract45010oralfinal/18031285 asco2012abstract45010oralfinal-130402000455-phpapp01
]]>
]]> Tue, 02 Apr 2013 00:04:55 GMT /slideshow/asco-2012-abstract45010oralfinal/18031285 pslice84@slideshare.net(pslice84) Asco 2012 abstract_45010_oral_final pslice84 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/asco2012abstract45010oralfinal-130402000455-phpapp01-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br>
Asco 2012 abstract_45010_oral_final from James Hilbert
]]> 475 3 https://cdn.slidesharecdn.com/ss_thumbnails/asco2012abstract45010oralfinal-130402000455-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Company presentation /slideshow/company-presentation-18012684/18012684 endocytecompanypresentation-130401164818-phpapp01
]]>
]]> Mon, 01 Apr 2013 16:48:18 GMT /slideshow/company-presentation-18012684/18012684 pslice84@slideshare.net(pslice84) Company presentation pslice84 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/endocytecompanypresentation-130401164818-phpapp01-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br>
Company presentation from James Hilbert
]]> 460 2 https://cdn.slidesharecdn.com/ss_thumbnails/endocytecompanypresentation-130401164818-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 5 understanding some basic trial designs in sarcomas (inclusive a placebo one) prof van der graaf nl /slideshow/5-understanding-some-basic-trial-designs-in-sarcomas-inclusive-a-placebo-one-prof-van-der-graaf-nl/16899617 5understandingsomebasictrialdesignsinsarcomasinclusiveaplacebooneprofvandergraafnl-130303103435-phpapp01
]]>
]]> Sun, 03 Mar 2013 10:34:35 GMT /slideshow/5-understanding-some-basic-trial-designs-in-sarcomas-inclusive-a-placebo-one-prof-van-der-graaf-nl/16899617 pslice84@slideshare.net(pslice84) 5 understanding some basic trial designs in sarcomas (inclusive a placebo one) prof van der graaf nl pslice84 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/5understandingsomebasictrialdesignsinsarcomasinclusiveaplacebooneprofvandergraafnl-130303103435-phpapp01-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br>
5 understanding some basic trial designs in sarcomas (inclusive a placebo one) prof van der graaf nl from James Hilbert
]]> 1107 3 https://cdn.slidesharecdn.com/ss_thumbnails/5understandingsomebasictrialdesignsinsarcomasinclusiveaplacebooneprofvandergraafnl-130303103435-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Transforming time for prostate cancer therapies /slideshow/transforming-time-for-prostate-cancer-therapies/15799270 transformingtimeforprostatecancertherapies-121229214025-phpapp01
]]>
]]> Sat, 29 Dec 2012 21:40:25 GMT /slideshow/transforming-time-for-prostate-cancer-therapies/15799270 pslice84@slideshare.net(pslice84) Transforming time for prostate cancer therapies pslice84 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/transformingtimeforprostatecancertherapies-121229214025-phpapp01-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br>
Transforming time for prostate cancer therapies from James Hilbert
]]> 952 6 https://cdn.slidesharecdn.com/ss_thumbnails/transformingtimeforprostatecancertherapies-121229214025-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 1 s2.0-s1470204510701327-main /pslice84/1-s20s1470204510701327main 1-s2-0-s1470204510701327-main-120910085451-phpapp02
]]>
]]> Mon, 10 Sep 2012 08:54:49 GMT /pslice84/1-s20s1470204510701327main pslice84@slideshare.net(pslice84) 1 s2.0-s1470204510701327-main pslice84 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/1-s2-0-s1470204510701327-main-120910085451-phpapp02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br>
1 s2.0-s1470204510701327-main from James Hilbert
]]> 472 4 https://cdn.slidesharecdn.com/ss_thumbnails/1-s2-0-s1470204510701327-main-120910085451-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Phase 2b emerge study of cdx 011 /slideshow/phase-2b-emerge-study-of-cdx-011/13314274 phase2bemergestudyofcdx-011-120613150630-phpapp02
]]>
]]> Wed, 13 Jun 2012 15:06:28 GMT /slideshow/phase-2b-emerge-study-of-cdx-011/13314274 pslice84@slideshare.net(pslice84) Phase 2b emerge study of cdx 011 pslice84 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/phase2bemergestudyofcdx-011-120613150630-phpapp02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br>
Phase 2b emerge study of cdx 011 from James Hilbert
]]> 652 7 https://cdn.slidesharecdn.com/ss_thumbnails/phase2bemergestudyofcdx-011-120613150630-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Bmn 110 ph12 results /slideshow/bmn-110-ph12-results/13312136 bmn110ph12results-120613111651-phpapp01
]]>
]]> Wed, 13 Jun 2012 11:16:49 GMT /slideshow/bmn-110-ph12-results/13312136 pslice84@slideshare.net(pslice84) Bmn 110 ph12 results pslice84 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/bmn110ph12results-120613111651-phpapp01-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br>
Bmn 110 ph12 results from James Hilbert
]]> 656 3 https://cdn.slidesharecdn.com/ss_thumbnails/bmn110ph12results-120613111651-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 The combos study an expert interview with william s /slideshow/the-combos-study-an-expert-interview-with-william-s/12195963 thecombosstudyanexpertinterviewwithwilliams-120328122459-phpapp02
]]>
]]> Wed, 28 Mar 2012 12:24:56 GMT /slideshow/the-combos-study-an-expert-interview-with-william-s/12195963 pslice84@slideshare.net(pslice84) The combos study an expert interview with william s pslice84 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/thecombosstudyanexpertinterviewwithwilliams-120328122459-phpapp02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br>
The combos study an expert interview with william s from James Hilbert
]]> 568 4 https://cdn.slidesharecdn.com/ss_thumbnails/thecombosstudyanexpertinterviewwithwilliams-120328122459-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 $MAPP Phase 3 results /slideshow/mapp-phase-3-results/12151377 mappphase3results-120325154512-phpapp01
]]>
]]> Sun, 25 Mar 2012 15:45:09 GMT /slideshow/mapp-phase-3-results/12151377 pslice84@slideshare.net(pslice84) $MAPP Phase 3 results pslice84 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/mappphase3results-120325154512-phpapp01-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br>
$MAPP Phase 3 results from James Hilbert
]]> 476 5 https://cdn.slidesharecdn.com/ss_thumbnails/mappphase3results-120325154512-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Novel therapies in hcc /slideshow/novel-therapies-in-hcc/10811306 noveltherapiesinhcc-120104232902-phpapp01
]]>
]]> Wed, 04 Jan 2012 23:29:00 GMT /slideshow/novel-therapies-in-hcc/10811306 pslice84@slideshare.net(pslice84) Novel therapies in hcc pslice84 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/noveltherapiesinhcc-120104232902-phpapp01-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br>
Novel therapies in hcc from James Hilbert
]]> 801 3 https://cdn.slidesharecdn.com/ss_thumbnails/noveltherapiesinhcc-120104232902-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 12702889 /slideshow/12702889/10025982 12702889-111104092145-phpapp01
AMRN 11/4 nonfinal rejection patent]]>
AMRN 11/4 nonfinal rejection patent]]> Fri, 04 Nov 2011 09:21:43 GMT /slideshow/12702889/10025982 pslice84@slideshare.net(pslice84) 12702889 pslice84 AMRN 11/4 nonfinal rejection patent <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/12702889-111104092145-phpapp01-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> AMRN 11/4 nonfinal rejection patent
12702889 from James Hilbert
]]> 348 5 https://cdn.slidesharecdn.com/ss_thumbnails/12702889-111104092145-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Nsclc 2nd line /slideshow/nsclc-2nd-line/8814224 nsclc2ndline-110809223418-phpapp02
]]>
]]> Tue, 09 Aug 2011 22:34:14 GMT /slideshow/nsclc-2nd-line/8814224 pslice84@slideshare.net(pslice84) Nsclc 2nd line pslice84 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/nsclc2ndline-110809223418-phpapp02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br>
Nsclc 2nd line from James Hilbert
]]> 878 1 https://cdn.slidesharecdn.com/ss_thumbnails/nsclc2ndline-110809223418-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Docetaxel Versus Docetaxel/Cisplatin in NSCLC /slideshow/nsclc-2ndline/8814211 fulltext-110809223210-phpapp01
]]>
]]> Tue, 09 Aug 2011 22:32:07 GMT /slideshow/nsclc-2ndline/8814211 pslice84@slideshare.net(pslice84) Docetaxel Versus Docetaxel/Cisplatin in NSCLC pslice84 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/fulltext-110809223210-phpapp01-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br>
Docetaxel Versus Docetaxel/Cisplatin in NSCLC from James Hilbert
]]> 559 4 https://cdn.slidesharecdn.com/ss_thumbnails/fulltext-110809223210-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease (Review) /slideshow/second-or-third-additional-chemotherapy-drug-for-nonsmall-cell-lung-cancer-in-patients-with-advanced-disease-review/8814210 cd004569-110809223212-phpapp01
]]>
]]> Tue, 09 Aug 2011 22:32:06 GMT /slideshow/second-or-third-additional-chemotherapy-drug-for-nonsmall-cell-lung-cancer-in-patients-with-advanced-disease-review/8814210 pslice84@slideshare.net(pslice84) Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease (Review) pslice84 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/cd004569-110809223212-phpapp01-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br>
Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease (Review) from James Hilbert
]]> 845 5 https://cdn.slidesharecdn.com/ss_thumbnails/cd004569-110809223212-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 $SNGX Nnational.2.1.2010 /slideshow/sngx-nnational212010/8600607 sngx-national-2-1-2010-110714204643-phpapp02
$SNGX National Securities Feb 2010]]>
$SNGX National Securities Feb 2010]]> Thu, 14 Jul 2011 20:46:38 GMT /slideshow/sngx-nnational212010/8600607 pslice84@slideshare.net(pslice84) $SNGX Nnational.2.1.2010 pslice84 $SNGX National Securities Feb 2010 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/sngx-national-2-1-2010-110714204643-phpapp02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> $SNGX National Securities Feb 2010
$SNGX Nnational.2.1.2010 from James Hilbert
]]> 367 3 https://cdn.slidesharecdn.com/ss_thumbnails/sngx-national-2-1-2010-110714204643-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Cbli 2011 05 25 barda /slideshow/cbli-2011-05-25-barda/8142133 cbli20110525barda-110529110836-phpapp01
CBLI Wedbush May 2011 update]]>
CBLI Wedbush May 2011 update]]> Sun, 29 May 2011 11:08:31 GMT /slideshow/cbli-2011-05-25-barda/8142133 pslice84@slideshare.net(pslice84) Cbli 2011 05 25 barda pslice84 CBLI Wedbush May 2011 update <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/cbli20110525barda-110529110836-phpapp01-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> CBLI Wedbush May 2011 update
Cbli 2011 05 25 barda from James Hilbert
]]> 442 3 https://cdn.slidesharecdn.com/ss_thumbnails/cbli20110525barda-110529110836-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 https://public.slidesharecdn.com/v2/images/profile-picture.png not telling none https://cdn.slidesharecdn.com/ss_thumbnails/protalixanalystdaypresentationjune202013v2-140211191137-phpapp01-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/protalix-analyst-day-presentation/31102390 Protalix analyst day p... https://cdn.slidesharecdn.com/ss_thumbnails/aldoxorubicin-p2-sts-01ctosposter10-31-13-131230092749-phpapp02-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/aldoxorubicin-p2sts01-ctos-poster-103113/29573322 Aldoxorubicin p2-sts-0... https://cdn.slidesharecdn.com/ss_thumbnails/ttrsc-130613163505-phpapp01-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/ttrsc/22941816 Ttrsc